The proposed rule also allows CMS to request and collect information directly from pharmacy benefit managers, pharmacies, and other entities that contract with Part D sponsors in order to better detect fraud, and increases CMS' ability to collect identified Medicare overpayments from Medicare Advantage (MA) plans and Part D sponsors.